| Overview |
| bs-6558R-PE |
| OLFM4 Polyclonal Antibody, PE Conjugated |
| WB |
| Mouse, Rat |
| Human, Dog, Cow, Pig, Rabbit |
| Specifications |
| PE |
| Rabbit |
| KLH conjugated synthetic peptide derived from human OLFM4 |
| 111-510/510 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 10562 |
| Q6UX06 |
| Cytoplasm, Secreted, Cell membrane, Extracellular matrix |
| GC1; OLM4; OlfD; GW112; hGC-1; hOLfD; UNQ362; bA209J19.1; Olfactomedin-4; Antiapoptotic protein GW112; G-CSF-stimulated clone 1 protein; OLFM4; UNQ362/PRO698 |
| May promote proliferation of pancreatic cancer cells by favoring the transition from the S to G2/M phase. In myeloid leukemic cell lines, inhibits cell growth and induces cell differentiation and apoptosis. May play a role in the inhibition of EIF4EBP1 phosphorylation/deactivation. Facilitates cell adhesion, most probably through interaction with cell surface lectins and cadherin. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz